medicina58巻10号

2021年09月発行

特集 腎疾患—エキスパートへの質問で学ぶ診療のキホンと最新情報 利尿薬やその他の新薬の有効性と注意すべき副作用

「尿が出ない！」だから利尿薬を投与する？利尿薬投与の基本と最新の使用法について教えてください

著者： 緒方聖友¹ 谷澤雅彦¹ 柴垣有吾¹

所属機関： ¹聖マリアンナ医科大学腎臓・高血圧内科

ページ範囲：P.1628 - P.1634

Point
◎利尿薬の作用機序を理解する．
◎ループ利尿薬をもとに各疾患での利尿薬のPK/PDについて理解する．
◎利尿薬抵抗性への対応理解を深める．

参考文献

1）柴垣有吾：より理解を深める！体液電解質異常と輸液 改訂3版，中外医学社，p 28, 2007

2）Ellison DH, Felker GM：Diuretic treatment in heart failure.N Engl J Med 377：1964-1975, 2017

3）Palmer BF：Metabolic complications associated with use of diuretics. Semin Nephrol 31：542-552, 2011

4）Ellison DH：Clinical pharmacology in diuretic use. Clin J Am Soc Nephrol 14：1248-1257, 2019

5）Hoorn EJ, Ellison DH：Diuretic resistance. Am J Kidney Dis 69：136-142, 2017

6）Brater DC：Update in diuretic therapy；Clinical pharmacology. Semin Nephrol 31：483-494, 2011

7）Vargo DL, et al：Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 57：601-609, 1995

8）Brater DC, et al：Absorption and disposition of furosemide in congestive heart failure. Kidney Int 22：171-176, 1982

9）Mullens W, et al：The use of diuretics in heart failure with congestion；A position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21：137-155, 2019

10）Cox ZL, Testani JM：Loop diuretic resistance complicating acute heart failure. Heart Fail Rev 25：133-145, 2020

11）Hanberg JS, et al：Hypochloremia and diuretic resistance in heart failure；Mechanistic insights. Circ Heart Fail 9：10.1161, 2016

12）Rudy DW, et al：Loop diuretics for chronic renal insufficiency；A continuous infusion is more efficacious than bolus therapy. Ann Intern Med 115：360-366, 1991

13）Felker GM, et al：Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364：797-805, 2011

14）Zheng Z, et al：Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction. ESC Heart Fail 8：2070-2078, 2021

15）Mullens W, et al：Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53：589-596, 2009

16）Agarwal R, Sinha AD：Thiazide diuretics in advanced chronic kidney disease. J Am Soc Hypertens 6：299-308, 2012

17）Inomata T, et al：Effects of additive tolvaptan vs. increased furosemide on heart failure with diuretic resistance and renal impairment；Results from the K-STAR Study. Circ J 82：159-167, 2017

18）Kida K, et al：Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction；A pharmacokinetic and pharmacodynamic study. Clin Pharmacokinet 54：273-284, 2015

19）Bellomo R, Giantomasso DD：Noradrenaline and the kidney；Friends or foes? Crit Care 5：294-298, 2001

20）Abuelo JG：Normotensive ischemic acute renal failure. N Engl J Med 357：797-805, 2007

21）Hall JE, et al：Blood pressure and renal function during chronic changes in sodium intake；Role of angiotensin. Am J Physiol 239：F271-F280, 1980